{"SPADE_UN_19043": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_19043", "Peptide Name": "R[G4a]-SHa (RNST-2, Synthetic AMPs, retro-NST-2, XXD, XXA, UCLL1c; Derivative: RLFP-1; RLFP-2)", "Source": "Source: sequence reversal, designed, man-made sequences", "Family": "Not found", "Gene": "Not found", "Sequence": "FLKGLMGVIASLF", "Sequence Length": 13, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal", "Anti-MRSA", "Hemolytic", "Anticancer"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1395.75, "PI": 8.75, "Hydrophobicity": 1.84, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Abdullah SJ, Guan JS, Mu Y, Bhattacharjya S.2024", "Reference": "Antibiotics (Basel). 2024 Dec 13;13(12):1213. doi: 10.3390/antibiotics13121213.PubMed", "Title": "Synthesis of Temporin-SHa Retro Analogs with Lysine Addition/Substitution and Antibiotic Conjugation to Enhance Antibacterial, Antifungal, and Anticancer Activities."}], "Frequent Amino Acids": "LFG", "Absent Amino Acids": "CDEHNOPQRTUWY", "Basic Residues": 1, "Acidic Residues": 0, "Hydrophobic Residues": 9, "Polar Residues": 4, "Positive Residues": 1, "Negative Residues": 0, "Net Charge": 1, "Comments": "Sequence analysis: APD analysis reveals that this sequence is unique and shows only very low similarity (64.29%) toLausporin-1L:23%, G=F: 15%.Chemical modification:  A10 is D-amino acid; C-terminal amidation.Activity: active against Gram+ S. aureus NCTC 13277 MRSA (MIC 3.12 uM), B. subtilis ATCC 23857 (MIC 1.56 uM), Gram- S. typhi ATCC 14028 (MIC 50 uM), E. coli ATCC 25922 (MIC 50 uM), P.aeruginosa ATCC 10145 (MIC 200 uM), and fungi C. albicans ATCC 36082 (MIC 15.6 uM).Structure:  helical in 20 mM SDS.In vitro toxicity: human RBC: HC50 13.8 uM; hemolytic. Breast cancer cells MCF-7 (IC50 53 uM), cervical cancer Hela cells (IC50 60 uM).SAR: conjugation of XX with the C-terminal lysine sidechain led to RLFP-1;\nconjugation of XX with the sidechain of K3 led to RLFP-2;", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_17517", "Similarity": 1.0, "Sequence": "IFGTILGFLKGL"}, {"SPADE_ID": "SPADE_UN_19045", "Similarity": 1.0, "Sequence": "FLKGLMGVIASLFK"}, {"SPADE_ID": "SPADE_UN_19044", "Similarity": 0.9230769230769231, "Sequence": "FLKKLMGVIASLF"}]}}}